164 related articles for article (PubMed ID: 15506646)
1. Expression of maspin and kai1 and their clinicopathological significance in carcinogenesis and progression of gastric cancer.
Zheng HC; Wang MC; Li JY; Yang XF; Sun JM; Xin Y
Chin Med Sci J; 2004 Sep; 19(3):193-8. PubMed ID: 15506646
[TBL] [Abstract][Full Text] [Related]
2. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer.
Wang MC; Yang YM; Li XH; Dong F; Li Y
World J Gastroenterol; 2004 Mar; 10(5):634-7. PubMed ID: 14991928
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
4. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
5. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
6. Pathobiological significance of vascular endothelial growth factor and Maspin expressions in human gastric carcinoma.
Li JJ; Chen Y; Zhang SM; Wu DY; Wang YP; Xin Y
World J Gastroenterol; 2004 Sep; 10(18):2624-7. PubMed ID: 15309707
[TBL] [Abstract][Full Text] [Related]
7. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.
Lee DY; Park CS; Kim HS; Kim JY; Kim YC; Lee S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):13-8. PubMed ID: 18091326
[TBL] [Abstract][Full Text] [Related]
8. [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray].
Wang XY; Liu T; Zhu CZ; Li Y; Sun R; Sun CY; Wang AX
Ai Zheng; 2005 Sep; 24(9):1091-5. PubMed ID: 16159431
[TBL] [Abstract][Full Text] [Related]
9. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
[TBL] [Abstract][Full Text] [Related]
10. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
12. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer.
Hinoda Y; Adachi Y; Takaoka A; Mitsuuchi H; Satoh Y; Itoh F; Kondoh Y; Imai K
Cancer Lett; 1998 Jul; 129(2):229-34. PubMed ID: 9719466
[TBL] [Abstract][Full Text] [Related]
14. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
[TBL] [Abstract][Full Text] [Related]
15. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
16. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
17. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
18. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
19. Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products.
Zheng HC; Li YL; Sun JM; Yang XF; Li XH; Jiang WG; Zhang YC; Xin Y
World J Gastroenterol; 2003 Aug; 9(8):1662-6. PubMed ID: 12918097
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Huachuan Z; Xiaohan L; Jinmin S; Qian C; Yan X; Yinchang Z
Chin Med Sci J; 2003 Jun; 18(2):80-6. PubMed ID: 12903787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]